Soft Tissue Allografts Market Research Report

Soft Tissue Allografts Market - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast 2017 - 2025
A fresh study by Transparency Market Research (TMR) notifies that the
global soft tissue allografts market was dominated by Allergan, plc. in 2016,
and the company is poised to sustain its strong market position in the near
future via its impressive product portfolio, geographical presence, and
frequent strategic acquisitions. For example, Allergan completed the
acquisition of Acelity L.P. Inc.’s LifeCell Corporation for US$2.9 bn in
February 2017. This move will help the company to make a foray into
regenerative medicine and add to its high-quality and durable portfolio.
Besides the commercial products of LifeCell, Allergan will also acquire the
New Jersey Company’s innovative manufacturing capabilities and its
research and development operations.
Browse Full Research Report:
https://www.transparencymarketresearch.com/soft-tissue-allograftsmarket.html
The TMR report also identifies some of the other prominent companies
currently operating in the global soft tissue allografts market, namely Zimmer
Biomet, Lattice Biologics Ltd., AlonSource Group, AlloSource, MiMedix
Group, Inc., CONMED Corporation, Organogenesis Inc., RTI Surgical, Inc.,
Integra LifeSciences Corporation, Globus Medical Inc, Straumann Holding
AG, Osiris Therapeutics, Inc., Arthrex, Inc., Xtant Medical, Alliqua
BioMedical, Inc, C. R. Bard, Inc (Davol Inc.), B. Braun Melsungen AG, and
Bone Bank Allograft.
As per the projections of the TMR report, the demand in the global soft tissue
allografts market will swell at a healthy CAGR of 6.3% during the forecast
period of 2017 to 2025. The report estimates the market for soft tissue
allografts, across the world, to be worth US$6.2 bn by the end of 2025,
substantially up from its evaluated valuation of US$3.6 bn in 2016. Based on
product type, collagen allograft was the most profitable segment, owing to its
applications in aesthetics surgery, wound care, and orthopedic surgeries.
Application-wise, wound care category held major market share in 2016,
followed by dentistry. Geographically, North America currently serves the
maximum demand in the global soft tissue allografts market.
For well over a century, soft tissue allografts have been considered a
successful procedure, and each year, nearly 1 million allografts are
transplanted in the U.S. alone. Soft tissue allografts are substitute tissues that
are used to reconstruct deficient ligaments, spinal surgery, torn menisci, and
osteochondral defects during knee surgery. Soft tissue allografts undergo a
three-stage safety screening process of donor screening, laboratory testing,
and tissue preparation. Soft tissue allografts can be made up of bone, tendons,
cartilage, skin, heart valves, and veins used for transplant in different types of
surgeries.
In the recent past, the usage of soft tissue allografts has grown due to increase
in the number of cases in dental implants and orthopedic surgery. Escalating
geriatric population, growing demand for new technological advancement for
production of new tissues by tissue banks, and rise in demand of soft tissue
allografts among athletes of numerous sports and other walks of life are some
of the key factors driving the demand in the global soft tissue allografts
market. Increase in ACL surgery, escalating incidences of diabetes foot ulcer,
growing popularity of cosmetic surgery to treat facial disorders with new
technologies are some of the other factors favoring the global soft tissue
allografts market.
While high cost of procedures continues to challenge the market for soft
tissue allografts, especially in the emerging economies, the lack of defined
reimbursement policies is also obstructing the market expansion. In addition
to that, complications pertaining to increased risk of infection and immune
response such as disruption of infected anastomotic rigid line with a rupture,
microbial infection, and bowel formation is hindering the proper prosperity of
the global soft tissue allografts market.
Browse Full Press Release:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency Market
Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

As per the projections of the TMR report, the demand in the global soft tissue allografts market will swell at a healthy CAGR of 6.3% during the forecast period of 2017 to 2025.

Download Report